Pancreatic Cancer Conference 2014 Teleconferences

The AACR hosted two press teleconferences during its special conference on Pancreatic Cancer: Innovations in Research and Treatment, May 18-21, 2014, in New Orleans.

Monday, May 19: This teleconference highlights the following research:

  • Pancreatic Cancer Projected to Become Second Leading Cause of Cancer-related Death in the United States by 2030;
  • Radioimmunotherapy and Gemcitabine Combination Shows Early Promise for Metastatic Pancreatic Ductal Cancer;
  • New Blood-based Biomarker Panel May Enable Pancreatic Cancer Diagnosis at an Early Stage; and
  • Potential New Therapeutic Approach Identified for Two Types of Pancreatic Cancer.

Wednesday, May 21: Conference leaders David Tuveson, M.D., Ph.D., The Lustgarten Foundation and ColdSpring Harbor Laboratories; Christine Iacobuzio-Donahue, M.D., Memorial Sloan Kettering Cancer Center; and Alec Kimmelman, M.D., Ph.D., Dana-Farber Cancer Institute, offer analysis of the conference, including discussion of new research areas and potential treatment options.

Page updated May 21, 2014.